These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 31343780)

  • 1. Griseofulvin vs terbinafine for paediatric tinea capitis: When and for how long.
    Bar J; Samuelov L; Sprecher E; Mashiah J
    Mycoses; 2019 Oct; 62(10):949-953. PubMed ID: 31343780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tinea capitis outbreak among paediatric refugee population, an evolving healthcare challenge.
    Mashiah J; Kutz A; Ben Ami R; Savion M; Goldberg I; Gan Or T; Zidan O; Sprecher E; Harel A
    Mycoses; 2016 Sep; 59(9):553-7. PubMed ID: 27061446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Laboratory monitoring during antifungal treatment of paediatric tinea capitis.
    Aleohin N; Bar J; Bar-Ilan E; Samuelov L; Sprecher E; Mashiah J
    Mycoses; 2021 Feb; 64(2):157-161. PubMed ID: 33064847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Terbinafine hydrochloride oral granules versus oral griseofulvin suspension in children with tinea capitis: results of two randomized, investigator-blinded, multicenter, international, controlled trials.
    Elewski BE; Cáceres HW; DeLeon L; El Shimy S; Hunter JA; Korotkiy N; Rachesky IJ; Sanchez-Bal V; Todd G; Wraith L; Cai B; Tavakkol A; Bakshi R; Nyirady J; Friedlander SF
    J Am Acad Dermatol; 2008 Jul; 59(1):41-54. PubMed ID: 18378354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic antifungal therapy for tinea capitis in children.
    Chen X; Jiang X; Yang M; González U; Lin X; Hua X; Xue S; Zhang M; Bennett C
    Cochrane Database Syst Rev; 2016 May; 2016(5):CD004685. PubMed ID: 27169520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A random comparative study of terbinafine versus griseofulvin in patients with tinea capitis in Western China.
    Deng S; Hu H; Abliz P; Wan Z; Wang A; Cheng W; Li R
    Mycopathologia; 2011 Nov; 172(5):365-72. PubMed ID: 21701791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved effectiveness of an increased dose of griseofulvin for treating Tinea capitis among refugee children in Israel: A retrospective cohort study.
    Kassem R; Barzilai A; Baum S; Kempfner A; Pavlotsky F
    Mycoses; 2023 Dec; 66(12):1064-1070. PubMed ID: 37620517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment outcomes for tinea capitis in a skin of color population.
    Bhanusali D; Coley M; Silverberg JI; Alexis A; Silverberg NB
    J Drugs Dermatol; 2012 Jul; 11(7):852-6. PubMed ID: 22777228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuous increase of Trichophyton tonsurans as a cause of tinea capitis in the urban area of Paris, France: a 5-year-long study.
    Gits-Muselli M; Benderdouche M; Hamane S; Mingui A; Feuilhade de Chauvin M; Guigue N; Picat MQ; Bourrat E; Petit A; Bagot M; Alanio A; Bretagne S
    Med Mycol; 2017 Jul; 55(5):476-484. PubMed ID: 27744309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pediatric tinea capitis caused by Trichophyton violaceum and Trichophyton soudanense in Rochester, Minnesota, United States.
    Grigoryan KV; Tollefson MM; Olson MA; Newman CC
    Int J Dermatol; 2019 Aug; 58(8):912-915. PubMed ID: 30548845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized, double-blind, parallel-group, duration-finding study of oral terbinafine and open-label, high-dose griseofulvin in children with tinea capitis due to Microsporum species.
    Lipozencic J; Skerlev M; Orofino-Costa R; Zaitz VC; Horvath A; Chouela E; Romero G; Gourmala N; Paul C;
    Br J Dermatol; 2002 May; 146(5):816-23. PubMed ID: 12000378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tinea capitis in children: a systematic review of management.
    Gupta AK; Mays RR; Versteeg SG; Piraccini BM; Shear NH; Piguet V; Tosti A; Friedlander SF
    J Eur Acad Dermatol Venereol; 2018 Dec; 32(12):2264-2274. PubMed ID: 29797669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic options for the treatment of tinea capitis caused by Trichophyton species: griseofulvin versus the new oral antifungal agents, terbinafine, itraconazole, and fluconazole.
    Gupta AK; Adam P; Dlova N; Lynde CW; Hofstader S; Morar N; Aboobaker J; Summerbell RC
    Pediatr Dermatol; 2001; 18(5):433-8. PubMed ID: 11737692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Griseofulvin and terbinafine in the treatment of tinea capitis in children.
    Rademaker M; Havill S
    N Z Med J; 1998 Feb; 111(1060):55-7. PubMed ID: 9539918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized comparison of 4 weeks of terbinafine vs. 8 weeks of griseofulvin for the treatment of tinea capitis.
    Fuller LC; Smith CH; Cerio R; Marsden RA; Midgley G; Beard AL; Higgins EM; Hay RJ
    Br J Dermatol; 2001 Feb; 144(2):321-7. PubMed ID: 11251566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy, safety and tolerability of terbinafine for Tinea capitis in children: Brazilian multicentric study with daily oral tablets for 1,2 and 4 weeks.
    Filho ST; Cucé LC; Foss NT; Marques SA; Santamaria JR
    J Eur Acad Dermatol Venereol; 1998 Sep; 11(2):141-6. PubMed ID: 9784040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic antifungal therapy for tinea capitis in children.
    González U; Seaton T; Bergus G; Jacobson J; Martínez-Monzón C
    Cochrane Database Syst Rev; 2007 Oct; (4):CD004685. PubMed ID: 17943825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New treatments for tinea capitis.
    Chan YC; Friedlander SF
    Curr Opin Infect Dis; 2004 Apr; 17(2):97-103. PubMed ID: 15021047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tinea capitis outbreak in a paediatric refugee population, Tel Aviv, Israel.
    Kopel E; Amitai Z; Sprecher H; Predescu S; Kaliner E; Volovik I
    Mycoses; 2012 Mar; 55(2):e36-9. PubMed ID: 21950325
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of terbinafine and griseofulvin in the treatment of tinea capitis.
    Cáceres-Ríos H; Rueda M; Ballona R; Bustamante B
    J Am Acad Dermatol; 2000 Jan; 42(1 Pt 1):80-4. PubMed ID: 10607324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.